We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
From Apr 2019 to Apr 2024
GlaxoSmithKline PLC (GSK.LN) said Tuesday it has entered into a strategic alliance with Dong-A Pharmaceuticals Co., Ltd., a pharmaceutical and OTC Company in South Korea.
MAIN FACTS:
-As part of the transaction, GSK will acquire a 9.9% minority equity shareholding in Dong-A for GBP73.9 million (KRW 142.9 billion).
-Dong-A has a portfolio of proprietary and generic pharmaceutical products and leading consumer healthcare brands.
-Last year, Dong-A reported total sales of GBP414 million (KRW 801 billion).
-The alliance will initially co-promote selected GSK and Dong-A pharmaceutical products for use in primary care.
-Additional synergies will be explored to strengthen both companies' commercial positions within the Korean pharmaceutical market.
-Under the terms of the agreement the companies will share profits generated from the co-promoted products above pre-agreed baselines.
-A new business unit will be created within Dong-A to manage the collaboration.
-GlaxoSmithKline shares closed Monday at 1187.5 pence.
-By Iain Packham, Dow Jones Newswires; 44-20-7842-9269; iain.packham@dowjones.com
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
